packageElinzanetant

elinzanetant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Elinzanetant is used to treat hot flashes associated with menopause, including in women with breast cancer. It is authorised in the European Union as a recently approved medicine.

Summary written by glm-5.3-flash from Wikidata Q108453435 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:elinzanetant
ATC codes:G02CX07
DrugBank:DB18968
PubChem CID:16063568
Wikidata:Q108453435
formula:C33H35F7N4O3
molar mass:668.654 g/mol (PubChem CID 16063568)

Metabolites

M1821M18/21molar mass unknown
M27M27molar mass unknown
M3034M30/34molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
M1821metabolite: M18/21
M27metabolite: M27
M3034metabolite: M30/34